Detection of Fentanyl and Fentanyl Analogs
Clinics in Laboratory Medicine · 2025
DOI: 10.1016/j.cll.2025.01.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Laboratory Medicine, 2025. Verfasst von Bridgit O Crews. Beteiligte Einrichtung: Department of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA. Electronic address: bridgit@wustl.edu. Hauptthemen laut MEDLINE: Fentanyl, Substance Abuse Detection, Analgesics, Opioid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Illicitly manufactured fentanyl and fentanyl analogs have led to a drastic increase in opioid related overdose deaths. Sensitive detection of fentanyl exposure requires specific assays that target fentanyl and its major metabolite norfentanyl. Fentanyl immunoassays have varying sensitivity to detect fentanyl analogs but many of the more prevalent analogs are not detected by routine fentanyl testing methods. This review focuses on the current state of both immunoassay and mass spectrometry-based testing methods for the detection of fentanyl and fentanyl analogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA. Electronic address: bridgit@wustl.edu.
Zitieren
APA
Crews, B. O. (2025). Detection of Fentanyl and Fentanyl Analogs. Clinics in Laboratory Medicine. https://doi.org/10.1016/j.cll.2025.01.012
Vancouver
Crews BO. Detection of Fentanyl and Fentanyl Analogs. Clinics in Laboratory Medicine. 2025. doi:10.1016/j.cll.2025.01.012
BibTeX
@article{Crews2025,
author = {Crews, Bridgit O},
title = {Detection of Fentanyl and Fentanyl Analogs},
journal = {Clinics in Laboratory Medicine},
year = {2025},
doi = {10.1016/j.cll.2025.01.012}
}
EUVIMED